(19)
(11) EP 4 264 275 A2

(12)

(88) Date of publication A3:
28.07.2022

(43) Date of publication:
25.10.2023 Bulletin 2023/43

(21) Application number: 21844465.1

(22) Date of filing: 15.12.2021
(51) International Patent Classification (IPC): 
G01N 33/68(2006.01)
C12N 5/0775(2010.01)
A61K 35/12(2015.01)
A61P 9/00(2006.01)
A61K 35/28(2015.01)
(52) Cooperative Patent Classification (CPC):
G01N 33/6893; G01N 2800/325; G01N 2800/52; A61K 35/28; A61P 9/04
(86) International application number:
PCT/US2021/063645
(87) International publication number:
WO 2022/132986 (23.06.2022 Gazette 2022/25)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 15.12.2020 AU 2020904675
12.01.2021 AU 2021900059
10.09.2021 AU 2021902941
20.10.2021 AU 2021903365

(71) Applicant: Mesoblast International Sàrl
1217 Meyrin (CH)

(72) Inventors:
  • ITESCU, Silviu
    Melbourne, Victoria 3000 (AU)
  • BOROW, Kenneth
    New York, New York 10017 (US)
  • HAYES, Jack
    New York, New York 10017 (US)

(74) Representative: Thomann, William John 
ZSP Patentanwälte PartG mbB Hansastraße 32
80686 München
80686 München (DE)

   


(54) METHOD OF TREATING PROGRESSIVE HEART FAILURE IN SUBJECTS WITH CLASS II HEART FAILURE